Overcoming Real-World Barriers to TED Treatment
Prem S. Subramanian, MD, PhD
Andrea Lora Kossler, MD, FACS
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Applying CAS, EUGOGO, VISA: A Micro Case
Why Staging TED Correctly Matters Even When CAS Is Low
Kimberly Cockerham, MD
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Why QoL Measures Change TED Management
Designing Efficient Clinic Workflows for TED Therapy Access
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.